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Abstract—Magnetic nanoparticle hyperthermia is an alterna-
tive cancer treatment where magnetic nanoparticles are delivered
to the tumor. The magnetization response due to an alternating
magnetic ﬁeld causes the magnetic nanoparticles to act as a
heating power source and thermally damage the tumor cells.
The heating capability of magnetic nanoparticles depends on
their relaxation losses and thus on their material properties.
Heat transfer in biological tissues on the other hand depends
on the material properties of the biological tissue, as well
as the spatial distribution of the magnetic nanoparticles. This
paper presents an efﬁcient numerical calculation method for
assessing the temperature distribution in biological tissue when
considering magnetic nanoparticles and biological tissues with
speciﬁed material properties. We ﬁrstly investigate the effect of
polydisperse magnetite and maghemite magnetic nanoparticles
distributions on the temperature. We furthermore study the
inﬂuence of the spatial spread of the magnetic nanoparticles
inside the tumor on the temperature distribution and the as-
sociated thermal damage. The proposed numerical methodology
is able to predict temperature elevations in biological tissues due
to magnetic nanoparticle hyperthermia and can constitute an
important component for model-based optimization of magnetic
nanoparticle hyperthermia.
Index Terms—magnetic nanoparticles, hyperthermia, magnetic
properties, speciﬁc loss power
I. INTRODUCTION
MAGNETIC nanoparticle hyperthermia (MNH) is apromising cancer treatment. Before the treatment, mag-
netic nanoparticles (MNPs) are delivered either systemically
or by direct injection to the tumoral tissue. When exposed
to an alternating magnetic ﬁeld (AMF), different processes of
magnetization reversal arise and lead to magnetic losses that
result in heat [1]. A cell-killing effect is observed when the
local temperature in a biological tissue resides between 41 and
46∘C for a period of time [2]. Because biological tissue is only
weakly diamagnetic, MNH offers the potential for a precise
and tissue-speciﬁc thermal dose delivery [3].
The heating efﬁciency of magnetic nanoparticles is usually
expressed in terms of speciﬁc loss power (SLP) with unit
watts per gram of iron. Theoretical studies have attempted
to predict this heating efﬁciency as a function of the applied
magnetic ﬁeld amplitude and frequency. The linear response
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theory (LRT) is a popular theoretical framework describing
the hysteresis loop area of non-interacting single domain
MNPs when the magnetization is linear with the applied
external ﬁeld [4], [5]. LRT is suitable to predict the heating
efﬁciency of MNPs in the superparamagnetic regime [5]. In
this computational study, we will use a modiﬁed version of the
linear response theory in order to account for a non-negligible
anisotropy [5].
The theoretically predicted heating source of the super-
paramagnetic nanoparticles acts as an input to the bioheat
transfer model of Pennes [6]. The aim of this numerical study
is to analyze the output of the bioheat transfer model (i.e.
the temperature variations as well as the thermal damage in
biological tissues) when applying an AMF to magnetite and
maghemite magnetic nanoparticles. This paper proposes an
efﬁcient computational model to investigate the effect of su-
perparamagnetic nanoparticles properties on the heat transfer
in magnetic nanoparticle hyperthermia, offering the potential
of model-based optimization.
II. SPECIFIC LOSS POWER
Linear response theory describes the dynamic response of
an ensemble of non-interacting single domain MNPs to a time-
varying external magnetic ﬁeld having a certain amplitude 𝐻𝑎
and frequency 𝑓 (with associated angular frequency 𝜔). The
magnetization response of the MNPs to the externally applied
magnetic ﬁeld 𝐻(𝑡) = 𝐻𝑎 cos(𝜔𝑡) follows
𝑀(𝑡) = 𝐻𝑎 [𝜒
′ cos(𝜔𝑡) + 𝜒′′ sin(𝜔𝑡)] (1)
with the complex susceptibility being
𝜒 = 𝜒′ − 𝑗𝜒′′ (2)
The susceptibility 𝜒 is assumed to be independent of the
applied magnetic ﬁeld. Consequently, this theory is commonly
referred to as the linear response theory [5], [3]. The imaginary
part of (2) is responsible for the phase lag between the exter-
nally applied magnetic ﬁeld and the response magnetization of
the MNP and hence creating relaxation losses. The imaginary
susceptibility’s frequency-dependence can further be detailed
as [4], [5]
𝜒′′ =
𝜔𝜏
1 + (𝜔𝜏)2
𝜒𝑚,0 (3)
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with the static susceptibility 𝜒𝑚,0 that can be regarded as the
chord susceptibility corresponding to the Langevin equation:
𝜒𝑚,0 = 𝜒𝑚,𝑖
3
𝜉
[
coth(𝜉)− 1
𝜉
]
(4)
with 𝜉 = 𝜇0𝑀𝑠𝐻𝑎𝑉𝑚𝑘𝐵𝑇 . 𝜒𝑚,𝑖 is the initial susceptibility deter-
mined from differentiation of the Langevin equation:
𝜒𝑚,𝑖 =
𝜇0𝜙𝑀
2
𝑠 𝑉𝑚
3𝑘𝐵𝑇
(5)
with 𝜇0 the vacuum permeability, 𝑀𝑠 the saturation magne-
tization and 𝑉𝑚 = 43𝜋𝑟
3 the magnetic volume of a spherical
MNP with radius 𝑟, 𝑘𝐵 the Boltzmann constant and 𝑇 the
temperature. 𝜙 is the ferroﬂuid volume fraction. Carrey et al.
[5] propose a modiﬁcation of the traditional linear response
theory to account for the anisotropy of MNPs. A phenomeno-
logical ﬁt is provided for the initial susceptibility (5), i.e.
𝜒𝑚,𝑖 =
𝜇0𝜙𝑀
2
𝑠 𝑉𝑚
3𝑘𝐵𝑇
⋅
⎡
⎢⎣3− 2
1 +
(
𝐾𝑉𝑚
𝑘𝐵𝑇
/3.4
)1.47
⎤
⎥⎦ (6)
with 𝐾 being the anisotropy constant of the MNP.
The relaxation time 𝜏 in (3) consists of both Ne´el and
Brown relaxation phenomena with 𝜏𝑁 and 𝜏𝐵 as the respective
relaxation constants. The global relaxation constant can be
expressed as
𝜏 =
(
1
𝜏𝐵
+
1
𝜏𝑁
)−1
=
𝜏𝐵𝜏𝑁
𝜏𝐵 + 𝜏𝑁
(7)
and is an important factor for relaxation losses of superpara-
magnetic MNP with
𝜏𝑁 = 𝜏0 exp
(
𝐾𝑉𝑚
𝑘𝐵𝑇
)
(8)
and
𝜏𝐵 =
3𝜂𝑉ℎ
𝑘𝐵𝑇
(9)
𝜏0 in (8) is the inverse of the attempt frequency [7] and has
typical values in the order of nanoseconds. 𝜂 and 𝑉ℎ in (9)
are the solvent viscosity and the hydrodynamic volume of the
magnetic nanoparticles respectively. When assuming a shell
thickness 𝛿, 𝑉ℎ = 4(𝑟 + 𝛿)3/3𝜋.
The volumetric power loss 𝑃 (𝑊/𝑚3) can be derived by
multiplying the frequency with the hysteresis loop area:
𝑃 = 𝜋𝜇0𝜒𝑚,0𝐻
2
𝑎𝑓
𝜔𝜏
1 + (𝜔𝜏)2
(10)
For further details related to the derivation, we refer to [4], [5].
In magnetic nanoparticle hyperthermia literature, we usually
refer to the speciﬁc loss power (SLP) instead of the volumetric
power loss 𝑃 , i.e.
𝑆𝐿𝑃LRT =
𝑃
𝜌𝜙
(11)
with 𝜌 the mass density of the magnetic material in 𝑔/𝑚3 such
that the dimension of SLP is 𝑊/𝑔Fe.
When considering a magnetic nanoparticle distribution, the
individual sizes of each MNP will not be identical due to
the production process [8]. In fact, the MNPs radii mostly
follow a log-normal particle size distribution. We will therefore
consider such polydisperse MNP populations that follow the
log-normal probability density function
𝑝(𝑟) =
1
𝜎𝑟𝑟
√
2𝜋
exp
[− ln2(𝑟/𝜇𝑟)
2𝜎2𝑟
]
(12)
with 𝜇𝑟 and 𝜎𝑟 being the mean and standard deviation of the
MNP radii. The associated speciﬁc loss power (11) has to be
weighted according to (12) [8]:
< 𝑆𝐿𝑃LRT >=
∫ ∞
0
𝑆𝐿𝑃LRT (𝑟) ⋅ 𝑝(𝑟) d𝑟, (13)
III. BIOHEAT TRANSFER
Heat transfer is the transfer of energy resulting from differ-
ences in temperature. The temperature variation in time and
space can be described by the biological heat transfer model
of Pennes [6]:
𝜌𝑡𝑐𝑝
∂𝑇
∂𝑡
= ∇ ⋅ (𝑘∇𝑇 )− 𝜔𝑏𝜌𝑏𝑐𝑏(𝑇 − 𝑇𝑏) + 𝑃MNP (14)
consisting of the biological tissue’s mass density 𝜌𝑡 and
speciﬁc heat capacity 𝑐𝑝. The right hand side consists of the
heat sources and sinks. The ﬁrst term is related to the heat
conduction with thermal conductivity 𝑘. The second term is
the heat sink due to blood perfusion (with blood temperature
𝑇𝑏 = 37
∘C where we assume that the heat transfer takes place
in the capillary bed, i.e. we assume that no large blood veins
are present in the considered volume). 𝜔𝑏 is the blood perfu-
sion rate, 𝜌𝑏 is the blood mass density, and 𝑐𝑏 is the speciﬁc
heat capacity of blood. The heat source originating from the
magnetic nanoparticles 𝑃MNP can be related to the speciﬁc
loss power (13) when considering magnetic nanoparticles with
a log-normal radius distribution (with associated 𝜇𝑟 and 𝜎𝑟).
We moreover consider that the magnetic nanoparticles are
normally distributed in space (with coordinates 𝑥, 𝑦, 𝑧), fol-
lowing the probability density function 𝑓MNP, yielding the
following heat power source:
𝑃MNP(𝑥, 𝑦, 𝑧) = 𝑚Fe⋅ < 𝑆𝐿𝑃LRT > ⋅𝑓MNP(𝑥, 𝑦, 𝑧) (15)
with
𝑓MNP(𝑥, 𝑦, 𝑧) =
1
𝜎3spread(2𝜋)
3/2
𝑒𝑥𝑝
[
−𝑥
2 + 𝑦2 + 𝑧2
2𝜎2spread
]
(16)
The spread of magnetic nanoparticles is described by 𝜎spread.
The percentage of magnetic nanoparticles situated in the tumor
is denoted by
𝑝𝑡 =
∫ 𝑟bound
0
𝑝(𝑟) d𝑟 (17)
with 𝑟bound being the outer radius of the considered spherical
tumor. By increasing the spread 𝜎spread, the percentage 𝑝𝑡 will
decrease.
Equation (14) is solved by means of an accurate and efﬁcient
ﬁnite element implementation following [9]. The reduction
from 3D to 1D is possible due to the assumed spherically
symmetrical geometry and symmetrical spatial distribution of
MNPs (16). The meshing is performed using Gmsh [10] and
the numerical ﬁnite element calculations are performed using
GetDP [11]. The time-stepping is carried out by a Crank-
Nicholson scheme with ﬁxed time step. In contrast to [9], we
develop a computational model that does not have the SLP as a
given heat source value but where the SLP is now numerically
determined by means of (13).
Due to the elevated temperatures during the treatment, the
biological tissue becomes thermally damaged. This thermal
damage can be modeled by an Arrhenius model [12]
𝛼 = exp
[
−
∫ 𝑡
0
𝐴𝑒
(
− Δ𝐸𝑎
𝑅⋅𝑇 (r,𝑡′)
)
d𝑡′
]
(18)
with the gas constant 𝑅, frequency factor 𝐴 and activation
energy barrier Δ𝐸𝑎. The temperature evolution at a certain
point in space thus speciﬁes the survival fraction 𝛼, i.e. the
concentration of living cells compared to its initial concentra-
tion.
IV. RESULTS AND DISCUSSION
The assumed alternating magnetic ﬁeld has a ﬁxed am-
plitude 𝐻𝑎 = 10 kA/m and frequency 𝑓 = 200 kHz. Two
types of superparamagnetic nanoparticles are considered in
our study, i.e. magnetite and maghemite nanoparticles with
magnetic material properties listed in Table I. The Ne´elian (9)
and Brownian (8) relaxation losses can be calculated using the
additional data in that table for a given radius 𝑟 of magnetic
nanoparticles. SLP calculations are performed in this study at
𝑇 = 37∘C. We additionally assume that the macroscopic tissue
temperature does not affect the relaxation losses. For a study
on the temperature dependence of magnetic nanoparticles
properties, we refer the reader to [13]. The bioheat transfer
equation (14) and the thermal damage (18) are calculated with
the constants provided in Table II. In this study, we assume a 1
cm3 spherical tumor (associated 𝑟bound = 6.204 mm) within a
spherical liver of radius 2 cm. The time stepping is performed
using a ﬁxed time step of 0.1 s.
TABLE I
MAGNETIC NANOPARTICLE MATERIAL PROPERTIES
Symbol (units) Value
Magnetite
𝐾 (kJ/m3) 23
𝑀𝑠 (kA/m) 446
Maghemite
𝐾 (kJ/m3) 4.7
𝑀𝑠 (kA/m) 414
𝜌 (kg/m3) 5260
𝜂 (Ns/m2) 0.0009
𝛿 (nm) 2
𝑚Fe (mg) 5
Figure 1 shows the temperature variation both in the center
of the tumor and averaged over the 1 cm3 tumor volume for
three different spatial distributions (16), i.e. 𝑝𝑡 = 95%, 80%
and 50% of MNPs situated in the tumor. The corresponding
𝜎spread values are given in Table III. We have a polydisperse
collection of magnetite nanoparticles with 𝜇𝑟 = 7 nm and
𝜎𝑟 = 0.01. This 𝜇𝑟 corresponds with the maximal SLP as
function of 𝜇𝑟, namely 𝑆𝐿𝑃LRT = 165.9 W/𝑔Fe. This ﬁgure
illustrates that although the temperature rises sufﬁciently high
TABLE II
HEAT TRANSFER AND BIOLOGICAL TISSUE PROPERTIES
Symbol (units) Value
𝜌𝑡 (kg/m3) 1060
𝑐𝑝 (J/(kg K)) 3500
𝑘 (W/(m K)) 0.53
𝜔𝑏 (s−1) 0.0064
𝜌𝑏 (kg/m3) 1000
𝑐𝑏 (J/(kg K)) 4180
𝐴 2.984 ⋅ 1080
Δ𝐸𝑎 5.064 ⋅ 105
𝑟bound (mm) 6.204
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Fig. 1. Temperature variation for magnetite MNPs (𝜇𝑟 = 7 nm and 𝜎𝑟 =
0.01) subjected to 𝐻𝑎 = 10 kA/m and 𝑓 = 200 kHz in the center of the
tumor (black) and averaged over the tumor (red) for three different 𝜎spread.
in the center of the tumor, the average rise is limited in the
tumor. Furthermore, the magnitude of the temperature rise sig-
niﬁcantly depends on the spatial spread of MNPs, highlighting
the importance of obtaining a sufﬁcient amount of MNPs in
the tumor. We observe the onset of an equilibrium state around
200 s (i.e. ∂𝑇∂𝑡 ≈ 0). Figure 2 depicts the survival fraction in
the center of the tumor (left) and averaged over the tumor
volume (right), analogous to ﬁgure 1. This ﬁgure illustrates
the effect of the spatial spread of magnetic nanoparticles on
the survival fraction values. When considering the center of the
tumor, virtually no cells survive if 𝑝𝑡 = 95%. If 𝑝𝑡 = 80%,
only 20% of the cells survive after 600 s. However, if one
looks at the average survival fraction in the tumor, maximum
20% of the cells are thermally damaged (𝑝𝑡 = 95%).
TABLE III
CONSIDERED SPATIAL SPREAD OF MAGNETIC NANOPARTICLES AND
CORRESPONDING PERCENTAGE OF MAGNETIC NANOPARTICLES IN THE
TUMOR
𝜎spread (m) 𝑝𝑡 (%)
0.00222 95
0.00290 80
0.00405 50
Further simulations were performed for magnetite and
maghemite particles where the mean radius 𝜇𝑟 of the poly-
disperse MNP population (with ﬁxed 𝜎𝑟 = 0.01) is varied.
We post-processed the results of the temperature and survival
fraction at 200 s, when equilibrium was achieved. The spatial
spread of magnetic nanoparticles is again varied. Figures 3 and
4 show the results for the temperatures and survival fraction
respectively.
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Fig. 2. Survival fraction variation for magnetite MNPs (𝜇𝑟 = 7 nm and
𝜎𝑟 = 0.01) subjected to 𝐻𝑎 = 10 kA/m and 𝑓 = 200 kHz in the center
of the tumor (left) and averaged over the tumor (right) for three different
𝜎spread.
Magnetite nanoparticles with a mean radius 𝜇𝑟 = 7 nm
achieve the highest temperature after 200 s. When decreasing
the amount of normally distributed MNPs in the tumor, the
temperature in the center decreases (ﬁgure 1). It clearly indi-
cates the importance of incorporating the spatial distribution
and thus the spatial spread in the heat transfer calculations.
One can also observe that the ratio of the temperature in the
center and the temperature at the boundary of the tumor (i.e.
at distance 𝑟bound) decreases for decreasing 𝑝𝑡. The same
trends hold for maghemite nanoparticles where maximum
temperatures are reached around 𝜇𝑟 = 11.5 nm. The obtained
temperatures are higher compared to magnetite MNPs because
they generate higher < 𝑆𝐿𝑃LRT > values, conﬁrming the
results in [8]. Nonetheless, therapeutic effects (𝑇 > 41∘C)
can be observed in both types of MNPs. However, magnetite
nanoparticles achieve these therapeutic temperatures in a larger
radius range than maghemite nanoparticles. When 𝑝𝑡 = 95%
for instance, magnetite nanoparticles with a mean radius
between 𝜇𝑟 ∈ [6.1− 13.9] nm have a maximum temperature
above 41∘C. Maghemite nanoparticles only have a limited
radius range to have a therapeutic effect: 𝜇𝑟 ∈ [9.9− 13.6] nm.
At the boundary of the tumor, the temperature is somewhat
lower for 𝑝𝑡 = 95% (39.6∘C) than for 𝑝𝑡 = 80% (40.5∘C)
and 𝑝𝑡 = 50% (40.2∘C). The average temperature in healthy
tissue remains at the baseline temperature (37∘C), mainly due
to the blood perfusion term in the heat transfer equation (14),
indicating that no healthy cells will be thermally damaged.
The survival fraction of the cells in the center of the tumor
is zero after 200 s for magnetite particles with 𝜇𝑟 = 7 nm or
maghemite particles with 𝜇𝑟 = 11.5 nm, spatially distributed
with 𝑝𝑡 = 95% of particles located in the tumor. However, due
to the limited temperatures at the boundary of the tumor, the
survival fraction remains close to 1 there. The heat transfer
simulations clearly conﬁrm that the challenge is to achieve a
decrease in survival fraction in the center as well as at the
tumor boundary. When increasing 𝐻𝑎 or the dose 𝑚Fe, the
𝑃MNP increases, yielding higher temperatures and decreasing
survival fraction. Temperatures in the center of the tumor may
reach unwanted high temperatures and almost no temperature
rise at the boundary of the tumor. The results presented here
suggest the importance of incorporating the spatial spread of
the particles in the analysis as well as the mean radius of the
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Fig. 3. Temperatures at 200 s when considering magnetite (left) and
maghemite (right) magnetic nanoparticles with varying mean radius 𝜇𝑟 . The
standard deviation was ﬁxed as 𝜎𝑟 = 0.01. We varied the spatial spread of the
magnetic nanoparticles inside the considered volume with varying percentage
of magnetic nanoparticle inside the tumor, i.e. 𝑝𝑡=95%, 80%, 50% in the
upper, middle and lower subﬁgure, respectively. The temperature in the center
of the tumor, temperature averaged over the tumor volume, temperature at the
boundary of the tumor, and the temperature in healthy tissue (being a shell
with inner radius of 6.2 mm and outer radius of 20 mm) are shown.
polydisperse magnetic nanoparticle population.
V. CONCLUSION
This paper presents a numerical model for magnetic
nanoparticle hyperthermia. The ﬁnite element model is able to
calculate the spatio-temporal temperature distribution and the
survival fraction of tumor cells. The linear response theory is
used to determine the heating efﬁciency of superparamagnetic
nanoparticles. We have additionally incorporated the effect of
a log-normal particle size distribution for both magnetite and
maghemite nanoparticles with their unique anisotropy constant
and saturation magnetization. The inﬂuence of the spatial
spread and thus the percentage of MNPs in the tumor was
studied as well. The temperature rise signiﬁcantly depends
on the spatial spread of MNPs, indicating the importance of
including the spatial distribution of MNPs. Finally, simulations
were performed while varying the mean radius of magnetite
and maghemite distributions. Again, the spatial spread plays
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Fig. 4. Survival fractions at 200 s when considering magnetite (left) and
maghemite (right) magnetic nanoparticles with varying mean radius 𝜇𝑟 . The
standard deviation was ﬁxed as 𝜎𝑟 = 0.01. We varied the spatial spread of the
magnetic nanoparticles inside the considered volume with varying percentage
of magnetic nanoparticle inside the tumor, i.e. 𝑝𝑡=95%, 80%, 50% in the
upper, middle and lower subﬁgure, respectively. The survival fraction in the
center of the tumor, survival fraction averaged over the tumor volume, and
survival fraction at the boundary of the tumor are shown.
a crucial role in obtaining therapeutic temperatures. Mag-
netite nanoparticles achieve a lower temperature rise than
their maghemite counterparts, but therapeutic temperatures are
obtained in a wider radius range. This computational model
can be an important component in optimizing the super-
paramagnetic nanoparticle properties towards the therapeutical
outcome.
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